BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
US Department of Justice
Express Scripts
Accenture
Cantor Fitzgerald
Mallinckrodt
Moodys
Boehringer Ingelheim
Merck

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072668

« Back to Dashboard

NDA 072668 describes TIMOLOL MALEATE, which is a drug marketed by Sandoz Inc, Akorn, Apotex Inc, Bausch And Lomb, Fdc Ltd, Fougera, Hi Tech Pharma, Pacific Pharma, Wockhardt, Mylan, Quantum Pharmics, Sandoz, Teva, Usl Pharma, and Watson Labs, and is included in thirty-eight NDAs. It is available from fifteen suppliers. There is one patent protecting this drug. Additional details are available on the TIMOLOL MALEATE profile page.

The generic ingredient in TIMOLOL MALEATE is timolol maleate. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.
Summary for 072668
Tradename:TIMOLOL MALEATE
Applicant:Mylan
Ingredient:timolol maleate
Patents:0
Therapeutic Class:Antimigraine Agents
Cardiovascular Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072668
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 072668
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TIMOLOL MALEATE timolol maleate TABLET;ORAL 072668 ANDA Mylan Pharmaceuticals Inc. 0378-0055 0378-0055-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0055-01)
TIMOLOL MALEATE timolol maleate TABLET;ORAL 072668 ANDA Mylan Pharmaceuticals Inc. 0378-0221 0378-0221-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0221-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jun 8, 1990TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jun 8, 1990TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Jun 8, 1990TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
US Army
Harvard Business School
Covington
Cantor Fitzgerald
McKesson
Novartis
Deloitte
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot